BIOE (Bio Essence) EV-to-EBIT : -6.89 (As of May. 19, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bio Essence EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bio Essence's Enterprise Value is $10.76 Mil. Bio Essence's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.56 Mil. Therefore, Bio Essence's EV-to-EBIT for today is -6.89.

The historical rank and industry rank for Bio Essence's EV-to-EBIT or its related term are showing as below:

BIOE' s EV-to-EBIT Range Over the Past 10 Years
Min: -1867.89 Med: -70.71 Max: -6.65
Current: -6.89

During the past 6 years, the highest EV-to-EBIT of Bio Essence was -6.65. The lowest was -1867.89. And the median was -70.71.

BIOE's EV-to-EBIT is ranked worse than
100% of 686 companies
in the Drug Manufacturers industry
Industry Median: 16.54 vs BIOE: -6.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bio Essence's Enterprise Value for the quarter that ended in Dec. 2024 was $11.86 Mil. Bio Essence's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.56 Mil. Bio Essence's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -13.17%.

Bio Essence EV-to-EBIT Historical Data

The historical data trend for Bio Essence's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Essence EV-to-EBIT Chart

Bio Essence Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

-44.56

-56.55

-7.59

Bio Essence Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															-56.55	-23.79	-458.05	-43.18	-7.59

Competitive Comparison of Bio Essence's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Bio Essence's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Essence's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bio Essence's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bio Essence's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Bio Essence EV-to-EBIT Calculation

Bio Essence's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	10.761	/	-1.562
	=	-6.89

Bio Essence's current Enterprise Value is $10.76 Mil.
Bio Essence's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.56 Mil.

Bio Essence (OTCPK:BIOE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bio Essence's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-1.562	/	11.863169
	=	-13.17 %

Bio Essence's Enterprise Value for the quarter that ended in Dec. 2024 was $11.86 Mil.
Bio Essence's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.56 Mil.

Bio Essence EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bio Essence's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio Essence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bio Essence Corp (OTCPK:BIOE) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

2955 Main Street, Suite 300, Irvine, CA, USA, 92618

Website

https://www.bioessencecorp.com

Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The company is focused on producing health products along with providing original equipment manufacturing and private label services to other companies. The company develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. The company also offers special formulated dietary supplements and medical food.